Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study. (Record no. 15340445)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01994 a2200565 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250514214539.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200503s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0959-8049 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.ejca.2004.08.026 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Nooij, M A |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20050322 |
245 00 - TITLE STATEMENT | |
Title | Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | European journal of cancer (Oxford, England : 1990) |
Date of publication, distribution, etc. | Jan 2005 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 225-30 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adolescent |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bone Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cisplatin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Combined Modality Therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease Progression |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Doxorubicin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Infusions, Intravenous |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lymphatic Metastasis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Rare Diseases |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sarcoma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Survival Analysis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Whelan, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bramwell, V H C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Taminiau, A T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cannon, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hogendoorn, P C W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pringle, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Uscinska, B M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Weeden, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kirkpatrick, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Glabbeke, M v |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Craft, A W |
773 0# - HOST ITEM ENTRY | |
Title | European journal of cancer (Oxford, England : 1990) |
Related parts | vol. 41 |
-- | no. 2 |
-- | p. 225-30 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.ejca.2004.08.026">https://doi.org/10.1016/j.ejca.2004.08.026</a> |
Public note | Available from publisher's website |
No items available.